Trump confirms possible drug reclassification, but stocks fall
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on US President Joe Biden “to…
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on US President Joe Biden “to…
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
Citigroup believes investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the…
Life sciences stocks are experiencing a resurgence, and that's good news for Danaher. Connecting the dots with better times ahead…
David Solomon, CEO of Goldman Sachs. Bloomberg | Bloomberg | fake images Goldman Sachs on Monday said it agreed to…
Eli Lilly shares rose Thursday after the drugmaker posted a strong third quarter, boosted by sales of its popular GLP-1…
Wall Street is optimistic that Olema Pharmaceuticals could be developing the next big breakthrough in breast cancer treatment. Earlier this…
It's been a stellar few months for the San Francisco-based biotech company's stock Rigel Pharmaceuticalswhich has approved treatments for hematology…
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified healthcare company turned in another less-than-stellar quarter. Revenue in…
Major banks, including JPMorgan Chase and Goldman Sachs He had just finished taking victory laps after a successful quarter when…